Guidant sues St Jude over cardiac devices:
This article was originally published in Clinica
Executive Summary
According to a US Securities and Exchange Commission filing by St Jude Medical, three of its heart devices are the subject of a patent infringement suit launched by rival Guidant. The suit was filed in the federal district court in Delaware. The disputed products are St Jude's Atlas HF and Epic HF ICD cardiac resynchronisation devices, and its Frontier CRM. The filing reported that the same patent was also involved in a lawsuit between Guidant and Medtronic, which both beat St Jude to market heart failure devices. St Jude is awaiting FDA approval for the Atlas and Epic devices.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.